{"id":"https://openalex.org/W2804862484","doi":"https://doi.org/10.1080/03007995.2018.1476332","title":"Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis","display_name":"Comparative efficacy of once-weekly semaglutide and SGLT-2 inhibitors in type 2 diabetic patients inadequately controlled with metformin monotherapy: a systematic literature review and network meta-analysis","alternate_titles":[],"publication_year":2018,"publication_date":"2018-05-29","ids":{"openalex":"https://openalex.org/W2804862484","doi":"https://doi.org/10.1080/03007995.2018.1476332","mag":"2804862484","pmid":"https://pubmed.ncbi.nlm.nih.gov/29764222"},"language":"en","primary_location":{"id":"doi:10.1080/03007995.2018.1476332","doi":"https://doi.org/10.1080/03007995.2018.1476332","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1476332","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2804862484"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/Comparative_efficacy_of_once-weekly_semaglutide_and_SGLT-2_inhibitors_in_type_2_diabetic_patients_inadequately_controlled_with_metformin_monotherapy_a_systematic_literature_review_and_network_meta-analysis/6272540","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101445893","display_name":"Rohini Sharma","orcid":"https://orcid.org/0000-0001-6194-0547","observed_orcids":["https://orcid.org/0000-0001-6194-0547"]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rohini Sharma","raw_affiliation_strings":["Precision Xtract, Vancouver, BC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Xtract, Vancouver, BC, Canada;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026271428","display_name":"Lars Wilkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lars Wilkinson","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054552742","display_name":"Hrvoje Vra\u017ei\u0107","orcid":"https://orcid.org/0000-0001-8151-9899","observed_orcids":["https://orcid.org/0000-0001-8151-9899"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hrvoje Vrazic","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000553290","display_name":"Evan Popoff","orcid":"https://orcid.org/0000-0002-3233-3147","observed_orcids":["https://orcid.org/0000-0002-3233-3147"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Evan Popoff","raw_affiliation_strings":["Precision Xtract, Vancouver, BC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Xtract, Vancouver, BC, Canada;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087540805","display_name":"Sarila Hali Kloster Lopes","orcid":"https://orcid.org/0000-0002-5697-3974","observed_orcids":["https://orcid.org/0000-0002-5697-3974"]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sandra Lopes","raw_affiliation_strings":["Novo Nordisk A/S, S\u00f8borg, Denmark;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, S\u00f8borg, Denmark;","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056574916","display_name":"Steve Kanters","orcid":"https://orcid.org/0000-0003-0322-5398","observed_orcids":["https://orcid.org/0000-0003-0322-5398"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steve Kanters","raw_affiliation_strings":["Precision Xtract, Vancouver, BC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Xtract, Vancouver, BC, Canada;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103442059","display_name":"Eric Druyts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric Druyts","raw_affiliation_strings":["Precision Xtract, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Precision Xtract, Boston, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101445893"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8274,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.63498675,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"34","issue":"9","first_page":"1595","last_page":"1603"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.8970000147819519},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9909999966621399},{"id":"https://openalex.org/keywords/metformin-monotherapy","display_name":"metformin monotherapy","score":0.8349999785423279},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8610000014305115},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9710000157356262},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.828000009059906},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.8650000095367432},{"id":"https://openalex.org/keywords/systolic-blood-pressure","display_name":"systolic blood pressure","score":0.8050000071525574},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.847000002861023},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.996999979019165},{"id":"https://openalex.org/keywords/treatment-intensification","display_name":"treatment intensification","score":0.6010000109672546}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9529097080230713},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9268963932991028},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8076949119567871},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7171250581741333},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.6859753131866455},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6141027212142944},{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.6032445430755615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5852134227752686},{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.5670365691184998},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.47761744260787964},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4671112298965454},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.45731306076049805},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.23904630541801453},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2151041328907013},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.13798850774765015}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/03007995.2018.1476332","doi":"https://doi.org/10.1080/03007995.2018.1476332","is_oa":false,"landing_page_url":"https://doi.org/10.1080/03007995.2018.1476332","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:29764222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29764222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"},{"id":"pmh:oai:figshare.com:article/6272540","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Comparative_efficacy_of_once-weekly_semaglutide_and_SGLT-2_inhibitors_in_type_2_diabetic_patients_inadequately_controlled_with_metformin_monotherapy_a_systematic_literature_review_and_network_meta-analysis/6272540","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"doi:10.6084/m9.figshare.6272540.v1","doi":"https://doi.org/10.6084/m9.figshare.6272540.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.6272540.v1","pdf_url":"https://doi.org/10.6084/m9.figshare.6272540.v1","source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/6272540","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Comparative_efficacy_of_once-weekly_semaglutide_and_SGLT-2_inhibitors_in_type_2_diabetic_patients_inadequately_controlled_with_metformin_monotherapy_a_systematic_literature_review_and_network_meta-analysis/6272540","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2804862484.pdf","grobid_xml":"https://content.openalex.org/works/W2804862484.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1497461844","https://openalex.org/W1643809894","https://openalex.org/W1983049273","https://openalex.org/W1985743763","https://openalex.org/W1989674525","https://openalex.org/W2004474087","https://openalex.org/W2016719032","https://openalex.org/W2023984564","https://openalex.org/W2030311010","https://openalex.org/W2033401611","https://openalex.org/W2055498944","https://openalex.org/W2056526409","https://openalex.org/W2057765075","https://openalex.org/W2059439623","https://openalex.org/W2060858984","https://openalex.org/W2072239150","https://openalex.org/W2077653789","https://openalex.org/W2101374656","https://openalex.org/W2105660444","https://openalex.org/W2113144077","https://openalex.org/W2122077393","https://openalex.org/W2125776201","https://openalex.org/W2130570549","https://openalex.org/W2134652590","https://openalex.org/W2144625636","https://openalex.org/W2150529573","https://openalex.org/W2160088494","https://openalex.org/W2162140339","https://openalex.org/W2167245776","https://openalex.org/W2168926920","https://openalex.org/W2401934785","https://openalex.org/W2414217396","https://openalex.org/W2604469807","https://openalex.org/W2618595585","https://openalex.org/W2787255324","https://openalex.org/W2793578368","https://openalex.org/W4236074123","https://openalex.org/W4239837977","https://openalex.org/W7062312767"],"related_works":["https://openalex.org/W2963090082","https://openalex.org/W3080722123","https://openalex.org/W4385326105","https://openalex.org/W2799276912","https://openalex.org/W2802523429","https://openalex.org/W4286308882","https://openalex.org/W3034350704","https://openalex.org/W7165679173","https://openalex.org/W3093123473","https://openalex.org/W4408921979"],"abstract_inverted_index":{"Objective:":[0],"Treatment":[1,84],"intensification":[2],"with":[3,45,50,121,208,244],"additional":[4],"anti-diabetic":[5],"agents":[6],"is":[7,228],"recommended":[8],"in":[9,40,56,68,117,139,143,187,234,239],"type":[10],"2":[11,37],"diabetes":[12],"(T2D)":[13],"for":[14,111,145,155,167,215],"patients":[15,42,241],"inadequately":[16,43,242],"controlled":[17,44,48,243],"on":[18],"metformin":[19,245],"monotherapy.":[20,246],"The":[21,136],"present":[22],"network":[23],"meta-analysis":[24],"(NMA)":[25],"evaluated":[26],"comparative":[27],"efficacy":[28,62],"and":[29,34,59,79,96,125,190,205,217],"safety":[30,218],"of":[31,129,185,202,223],"once-weekly":[32,130,146],"semaglutide":[33,131,147,176,226],"sodium-glucose":[35],"co-transporter":[36],"inhibitors":[38],"(SGLT-2is)":[39],"T2D":[41,240],"metformin.Methods:":[46],"Randomized":[47],"trials":[49,107],"\u226520":[51],"weeks":[52,89],"duration":[53],"were":[54,90,99,108,119,212],"searched":[55],"EMBASE,":[57],"MEDLINE,":[58],"CENTRAL.":[60],"Primary":[61],"outcomes":[63],"were:":[64],"change":[65,140],"from":[66,141,153],"baseline":[67,142],"HbA1c,":[69],"weight,":[70],"systolic":[71],"blood":[72,76,81],"pressure":[73],"(SBP),":[74],"post-prandial":[75],"glucose":[77,82],"(PPG),":[78],"fasting":[80],"(FPG).":[83],"effects":[85],"at":[86],"26":[87],"(\u00b14)":[88],"compared":[91,133,231],"using":[92],"Bayesian":[93],"NMAs.":[94],"Meta-regression":[95],"sensitivity":[97,203],"analysis":[98,204],"used":[100],"to":[101,134,165,221,232],"address":[102],"the":[103],"trial":[104],"heterogeneity.Results:":[105],"Eight":[106],"found":[109],"eligible":[110],"this":[112],"NMA.":[113],"Statistically":[114],"significant":[115],"reductions":[116],"HbA1c":[118,144],"observed":[120],"both":[122],"1.0":[123,148,177],"mg":[124,127,149,158,170,178],"0.5":[126],"doses":[128],"when":[132],"SGLT-2is.":[135],"mean":[137],"differences":[138],"vs":[150],"SGLT-2is":[151,184,233],"ranged":[152],"\u22120.66%":[154],"canagliflozin":[156],"300":[157],"(95%":[159,171],"Credible":[160],"Intervals":[161],"[CrI]:":[162],"\u22120.82,":[163],"\u22120.50%)":[164],"\u22121.11%":[166],"dapagliflozin":[168],"5":[169],"CrI:":[172],"\u22121.37,":[173],"\u22120.85%).":[174],"Once-weekly":[175,225],"performed":[179],"significantly":[180,229],"better":[181,230],"than":[182],"all":[183],"interest":[186],"reducing":[188],"weight":[189],"improving":[191],"FPG":[192],"levels:":[193],"however,":[194],"SBP":[195],"reduction":[196],"was":[197],"not":[198,213],"statistically":[199],"differentiable.":[200],"Results":[201],"meta-regressions":[206],"aligned":[207],"base-case":[209],"results.":[210],"NMAs":[211],"possible":[214],"PPG":[216],"outcomes,":[219],"due":[220],"lack":[222],"data.Conclusion:":[224],"treatment":[227],"achieving":[235],"adequate":[236],"glycemic":[237],"control":[238]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2804862484","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-06-01T00:00:00"}
